Executive Director, Medical Affairs & Evidence Generation Asset Lead

The Company is seeking an Executive Director for Medical Affairs and Evidence Generation, with a focus on a novel anti-IgA monoclonal antibody asset. The successful candidate will be at the forefront of the company's mission to transform immunology and deliver innovative medicines to help autoimmune patients. This strategic leadership role involves providing expert medical insights to guide the development and commercialization of the asset, with a strong emphasis on patient outcomes and access. The Executive Director will be responsible for the integrated evidence generation plans, working closely with global cross-functional teams, and will also serve as a people manager, overseeing the hiring, coaching, and development of medical affairs and evidence generation teams. Candidates for this role must have an advanced scientific degree (MD, PhD, PharmD, or equivalent) and a minimum of 15 years of experience in nephrology clinical practice, research, or specific nephrology biopharmaceutical industry experience. A strong background in medical affairs, including at least 5 years in the industry, is highly preferred. The role requires a deep understanding of complex disease areas, the ability to evaluate and interpret medical literature, and a proven track record in developing and executing medical affairs strategies. The ideal candidate will have excellent communication and interpersonal skills, the ability to work in a fast-paced, matrixed environment, and a collaborative approach to co-creation and problem-solving. Experience in drug development, rare diseases, and a network of industry experts are advantageous.